|
|
|
(6bR,12bR)-6bβ,12bβ-Dihydro-3,3-dimethyl-11-(3-methyl-2-butenyl)-3H,7H-furo[3,2-c:5,4-f']bis[1]benzopyran-10-ol |
(6bR,12bR)-6bβ,12bβ-Dihydro-3,3-dimethyl-11-(3-methyl-2-butenyl)-3H,7H-furo[3,2-c:5,4-f']bis[1]benzopyran-10-ol |
|
|
(6bR,14bR)-6b,12,13,14b-Tetrahydro-3,3,11,11-tetramethyl-3H,7H,11H-[1]benzopyrano[6',5':4,5]furo[3,2-c]pyrano[3,2-g][1]benzopyran |
(6bR,14bR)-6b,12,13,14b-Tetrahydro-3,3,11,11-tetramethyl-3H,7H,11H-[1]benzopyrano[6',5':4,5]furo[3,2-c]pyrano[3,2-g][1]benzopyran |
|
|
(11BR, 11'BR)-4,4'-(9,9-DIMETHYL-9H-XAN& |
(11BR,11′BR)-4,4′-(9,9-二甲基-9H-氧杂蒽-4,5-二基)双-二萘并[2,1-D:1′,2′-F][1,3,2]二噁磷杂庚英 |
|
|
(11BR, 11'BR)-4,4'-(OXYDI-2,1-PHENYLENE& |
(11BR, 11′BR)-4,4′-(氧代二-2,1-亚苯基)双-二萘并[2,1-D:, 1′, 2′-F][1,3,2]二噁磷环庚烷 |
|
|
(11bR,11'bR)-4,4'-(1S,2S)-1,2-cyclohexanediylbis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine |
(11BR,11'BR)-4,4'-(1S,2S)-1,2-CYCLOHEXANEDIYLBIS[4,5-DIHYDRO-H-DINAPHTH[2,1-C:1',2'-E]AZEPINE |
|
|
11bR,11'bR)- 4,4'-[(1S,2S)-1,2-diphenyl-1,2-ethanediyl]bis[4,5-dihydro-H-Dinaphth[2,1-c:1',2'-e]azepine |
11BR,11'BR)- 4,4'-[(1S,2S)-1,2-DIPHENYL-1,2-ETHANEDIYL]BIS[4,5-DIHYDRO-H-DINAPHTH[2,1-C:1',2'-E]AZEPINE |
|
|
(4bR)-4bα,6,7,8-Tetrahydro-8α-(4-hydroxy-3,5-dimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester |
(4bR)-4bα,6,7,8-Tetrahydro-8α-(4-hydroxy-3,5-dimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester |
|
|
(12bR)-3,4,8,12b-Tetrahydro-11-chloro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
(12bR)-3,4,8,12b-Tetrahydro-11-chloro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
|
|
(4bR)-4bα,6,7,8-Tetrahydro-8α-(3,4,5-trimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester |
(4bR)-4bα,6,7,8-Tetrahydro-8α-(3,4,5-trimethoxyphenyl)-7aH-furo[2',3':1,2]indeno[5,6-d]-1,3-dioxole-7aα-carboxylic acid methyl ester |
|
|
(12bR)-3,4,8,12b-Tetrahydro-8-methyl-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
(12bR)-3,4,8,12b-Tetrahydro-8-methyl-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
|
|
(12bR)-6,7,12bα,13-Tetrahydro-13β-methyl-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine |
(12bR)-6,7,12bα,13-Tetrahydro-13β-methyl-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine |
|
|
(12bR)-3,4,8,12b-Tetrahydro-12bα-methyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
(12bR)-3,4,8,12b-Tetrahydro-12bα-methyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
|
|
(12bR)-3,4,8,12b-Tetrahydro-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
(12bR)-3,4,8,12b-Tetrahydro-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
|
|
(12bR)-3,4,8,12b-Tetrahydro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
(12bR)-3,4,8,12b-Tetrahydro-12bα-phenyl-2H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-7(6H)-one |
|
|
BRD-8, aa25-75 (SMAP, p120, Bromodomain containing 8, SMAP, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
|
BRD-8, aa25-75 (SMAP, p120, Bromodomain containing 8, SMAP, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
|
|
|
BRD-8, aa200-250 (SMAP, p120, Bromodomain containing 8, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
|
BRD-8, aa200-250 (SMAP, p120, Bromodomain containing 8, Skeletal Muscle Abundant Protein, Thyroid hormone receptor coactivating protein p120)
|
|
|
(11bR)-2,6-Di-9-anthracenyl-4-hydroxy-dinaphtho[2,1-d:1μ,2μ-f][1,3,2]dioxaphosphepin-4-oxide |
(11BR)-2,6-二-9-蒽基-4-羟基-二萘[2,1-D:1',2'-F][1,3,2]二氧磷酸-4-氧化物 |
|
|
(11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide |
(11BR)-2,6-二-9-菲基-4-羟基-二萘并[2,1-D:1′,2′-F][1,3,2]二磷杂庚英-4-氧化物 |
|
|
Breast Cancer Resistance Protein (BCRP), ABCG2, Clone: BXP-21, Mab anti-Human, frozen/paraffin, IH/WB
|
Breast Cancer Resistance Protein (BCRP), ABCG2, Clone: BXP-21, Mab anti-Human, frozen/paraffin, IH/WB
|
|
|
|